Tradestie Institutional Equity Comparison Engine
SLS vs CAMP โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SLS Overall Edge
SLS Captures Institutional Edge (3โ0 Pillars ยท 4โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SELLAS Life Sciences Group, Inc. Common Stock (SLS) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SLS trades at N/M Forward P/E with 0.0% operating margin (-82.5% YoY revenue) versus CAMP at N/M Forward P/E and -991.8% operating margin (+138.9% YoY). In options structure, SLS sits in BREAKOUT (74th %ile IV; Dealer Gamma Walls on Pro) against CAMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
SLS N/M vs CAMP N/M Fwd P/E
Growth & Margin Winner
SLS
Op Margin 0.0% vs -991.8% ยท YoY -82.5% vs +138.9%
Momentum & Technical Winner
SLS
1Y +1239.2% vs -2.4% ยท 52W Pos 76% vs 23%
Options & Structure Winner
SLS
BREAKOUT (74th %ile IV) vs UNCLASSIFIED (N/A IV)
SLS
NASDAQ
SELLAS Life Sciences Group, Inc. Common Stock
Pharmaceutical Preparations
$19.15
+156.36% 1D
Market Cap
$1.6B
1M Return
+82.55%
1Y Return
+1239.16%
Forward P/E
N/M
Unified AI Score
34.1 / 100
SELL
Tech 5.0
Fund 37.0
Flow 66.0
Mom 38.9
CAMP
NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$4.00
+3.63% 1D
Market Cap
$238.5M
1M Return
+27.39%
1Y Return
-2.44%
Forward P/E
N/M
Unified AI Score
43.9 / 100
HOLD
Tech 34.0
Fund 40.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SLS +1239.16%
CAMP -2.44%
Spread: +1241.6 pp (SLS Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SLS Revenue | CAMP Revenue | SLS Op. Margin | CAMP Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2013 | $0M | N/A | -1145.5% | N/A | SLS |
| FY2014 | $10M | N/A | -471.1% | N/A | SLS |
| FY2020 | $0M | N/A | -893.8% | N/A | SLS |
| FY2021 | $10M | N/A | -332.8% | N/A | SLS |
| FY2022 | $0M | N/A | -4195.0% | N/A | SLS |
| FY2023 | N/A | $0M | N/A | -14822.6% | CAMP |
| FY2024 | N/A | $0M | N/A | -8142.3% | CAMP |
| FY2025 | N/A | $0M | N/A | -1502.4% | CAMP |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SLS | CAMP | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.6B | $238.5M | Larger Scale | SLS |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -82.5% | +138.9% | Higher Growth | CAMP |
| Operating Margin (TTM) Profitability | 0.0% | -991.8% | Higher Margin | SLS |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -40.3% | -146.1% | Higher ROE | SLS |
| 52-Week Range Position Momentum | 76% ($1โ$25) | 23% ($3โ$8) | Stronger Trend | SLS |
| Beta / 30D Volatility Risk Regime | 1.38ฮฒ ยท 568% Vol | 1.35ฮฒ ยท 94% Vol | Lower Realized Risk | CAMP |
| Unified Institutional Score Composite Signal | 34.1 / 100 (SELL) | 43.9 / 100 (HOLD) | Higher Composite | CAMP |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SLS vs CAMP Buy Guide
SLS
BREAKOUT
99d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
74th %ile
IV Regime
Elevated (60thโ80th %ile)
CAMP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SLS nor CAMP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.